These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26631821)

  • 21. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D; Wong M; Isaacs D
    J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
    Šileikienė R; Kudzytė J; Jankauskas A; Labanauskas L; Rakauskienė V; Jurkienė N; Kėvalas R
    Medicina (Kaunas); 2013; 49(7):341-5. PubMed ID: 24375247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
    Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M; Chaikitpinyo A; Durongpisitkul K; Somchit S; Petcharatana S; Wongswadiwat Y; Kosalaraksa P; Lumbiganon P
    J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
    Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kawasaki disease: etiopathogenesis and novel treatment strategies.
    Agarwal S; Agrawal DK
    Expert Rev Clin Immunol; 2017 Mar; 13(3):247-258. PubMed ID: 27590181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome.
    Saulsbury FT
    Clin Pediatr (Phila); 2002 Oct; 41(8):597-601. PubMed ID: 12403377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria.
    Kothur K; Singh S; Sharma Y; Mittal BR
    J Cardiol; 2007 Nov; 50(5):299-307. PubMed ID: 18044459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
    Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
    Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kawasaki disease.
    Kim DS
    Yonsei Med J; 2006 Dec; 47(6):759-72. PubMed ID: 17191303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kawasaki Disease: Issues in Diagnosis and Treatment--A Developing Country Perspective.
    Singh S; Sharma A; Jiao F
    Indian J Pediatr; 2016 Feb; 83(2):140-5. PubMed ID: 26400032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based management of Kawasaki disease in the emergency department.
    Seaton KK; Kharbanda A
    Pediatr Emerg Med Pract; 2015 Jan; 12(1):1-20; quiz 21. PubMed ID: 25693305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.